<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05627284</url>
  </required_header>
  <id_info>
    <org_study_id>2022-LCYJ-PY-33</org_study_id>
    <nct_id>NCT05627284</nct_id>
  </id_info>
  <brief_title>A Prospective Clinical Trial of Colostomy-replacement Combined With Bio-mesh Placement in the Prevention of SSIH</brief_title>
  <official_title>A Prospective Clinical Trial of Colostomy-replacement Combined With Bio-mesh Placement in the Prevention of SSIH</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical trial is to explore the safety and effectiveness of stoma reversal&#xD;
      combining bio-mesh placement in patients with high risk of stoma site incisional hernia&#xD;
      (SSIH). The main questions it aims to answer are:&#xD;
&#xD;
        -  Whether bio-mesh placement is safe for patients with a high risk of SSIH.&#xD;
&#xD;
        -  Whether stoma reversal combining bio-mesh placement is a preventive strategy for&#xD;
           patients with high risk of SSIH.&#xD;
&#xD;
        -  Whether stoma reversal combining bio-mesh placement will trigger other complications.&#xD;
&#xD;
      Participants who are eligible and are enrolled in this study will receive stoma reversal&#xD;
      combining bio-mesh placement surgery. After that, they will be followed up for one year to&#xD;
      evaluate the occurrence of SSIH and other complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2022</start_date>
  <completion_date type="Anticipated">September 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>stoma site incisional hernia</measure>
    <time_frame>one-year after surgery</time_frame>
    <description>Hernia occurs on the primary stoma site</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Stoma Site Incisional Hernia</condition>
  <arm_group>
    <arm_group_label>Stoma reversal with bio-mesh placement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stoma reversal with bio-mesh placement</intervention_name>
    <description>Patients will receive stoma reversal. During the surgery, a bio-mesh is placed beyond the peritoneum on the surgical site to strengthen the abdominal wall.</description>
    <arm_group_label>Stoma reversal with bio-mesh placement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 18-75 years old;&#xD;
&#xD;
          -  Patients should have colonic prophylactic stoma and have not received reversal yet;&#xD;
&#xD;
          -  There are no obvious signs of tumor recurrence or metastasis in tumor patients before&#xD;
             stoma resection;&#xD;
&#xD;
          -  No serious underlying diseases, can tolerate general anesthesia surgery&#xD;
&#xD;
          -  Preoperative ECOG (Eastern Cooperative Oncology Group) physical status score 0/1;&#xD;
&#xD;
          -  Preoperative ASA (American Society of Anesthesiologists) grade I-III;&#xD;
&#xD;
          -  Without vital organs function failure;&#xD;
&#xD;
          -  All patients and their families signed informed consent before surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Incapacitated persons;&#xD;
&#xD;
          -  With a history of other types of hernia;&#xD;
&#xD;
          -  Those who have had hernia mesh implantation before;&#xD;
&#xD;
          -  Those who are allergic to bio-mesh or their components before;&#xD;
&#xD;
          -  Combined with other surgeries;&#xD;
&#xD;
          -  Severe mental illness;&#xD;
&#xD;
          -  Severe respiratory disease;&#xD;
&#xD;
          -  Severe liver and kidney insufficiency;&#xD;
&#xD;
          -  Those who have absolute contraindications to surgery;&#xD;
&#xD;
          -  Suffering from severe bleeding disorders or obvious abnormal coagulation function;&#xD;
&#xD;
          -  History of unstable angina or myocardial infarction within 6 months;&#xD;
&#xD;
          -  History of cerebral infarction or cerebral hemorrhage within 6 months;&#xD;
&#xD;
          -  Continuous intravenous application of glucocorticoid within 1 month;&#xD;
&#xD;
          -  The patient has participated or is participating in other clinical studies (within 6&#xD;
             months).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yonghuan Mao, Dr</last_name>
    <phone>+86 15151877330</phone>
    <email>maoyonghuan@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nanjing Drum Tower Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meilin Jiang, Dr.</last_name>
      <phone>+86 025-68182923</phone>
      <email>gyethics@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2022</verification_date>
  <study_first_submitted>November 16, 2022</study_first_submitted>
  <study_first_submitted_qc>November 16, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2022</study_first_posted>
  <last_update_submitted>November 16, 2022</last_update_submitted>
  <last_update_submitted_qc>November 16, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stoma Site Incisional Hernia</keyword>
  <keyword>Colon cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Incisional Hernia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

